About Portola

Developing and commercializing therapies that advance patient care in thrombosis and other hematologic diseases.

Read More

Pipeline

Andexanet alfa and cerdulatinib

Read More

Now Approved

Learn more about Bevyxxa® (betrixaban).

Read More